Immune checkpoint inhibitor-associated pituitary adverse events: an observational, retrospective, disproportionality study

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.7K citations · Full text

Life Sciences, Immunology, Oncology +17

A Bayesian neural network method for adverse drug reaction signal generation

Andrew Bate, Marie Lindquist, I. Ralph Edwards et al. · European Journal of Clinical Pharmacology · 1998 · 1.4K citations

Pharmacy, Pharmacology, Toxicology +14

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

Alexander M.M. Eggermont, Vanna Chiarion‐Sileni, Jean‐Jacques Grob et al. · New England Journal of Medicine · 2016 · 1.3K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

Joe‐Elie Salem, Ali Manouchehri, Melissa Moey et al. · The Lancet Oncology · 2018 · 1.2K citations

Life Sciences, Immunology, Pharmacology +16

Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody

Shintaro Iwama, Alessandra De Remigis, Margaret K. Callahan et al. · Science Translational Medicine · 2014 · 705 citations

Medicine, Endocrinology, Immunology +17